MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Inflammatory Bowel Disease
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,452 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,452 works in the cohort · of 4,299,418page 52 of 130

Labels cover 21 of 6,452 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,452 of 6,452 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Vedolizumab for Crohn's disease
Mahmoud Mosli, Brian G. Feagan
2013· review· en· Expert Opinion on Biological Therapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
afffundno abstractunlabeled
Design of Clinical Trials for Mild to Moderate Ulcerative Colitis
Rocío Sedaño, Vipul Jairath, Christopher Ma, Jurji Hanzel, Lisa M. Shackelton, Stefanie C. McFarlane +3 more
2022· article· en· Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
affno abstractunlabeled
Management of Crohn's Disease After Surgical Resection
Siddharth Singh, Geoffrey C. Nguyen
2017· review· en· Gastroenterology Clinics of North America· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
afffundaboutunlabeled
Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network—A Joint Partnership of CIHR and the CH.I.L.D. Foundation
Wael El‐Matary, Eric I. Benchimol, David Mack, Hien Q. Huynh, Jeff Critch, Anthony Otley +14 more
2017· article· en· Canadian Journal of Gastroenterology and Hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
afffundno abstractunlabeled
Proteomics and Imaging in Crohn’s Disease: TAILS of Unlikely Allies
Barbara Mainoli, Simon A. Hirota, Laura E. Edgington‐Mitchell, Ping Lu, Antoine Dufour
2020· review· en· Trends in Pharmacological Sciences· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
affunlabeled
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies
Jean‐Frédéric Colombel, Stefan Schreiber, Geert D’Haens, Joanne Rizzo, Kristina Kligys, Jenny Griffith +7 more
2023· article· en· Journal of Crohn s and Colitis· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
afffundaboutunlabeled
The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape
Sanjay K. Murthy, Adam V. Weizman, M Ellen Kuenzig, Joseph W. Windsor, Gilaad G. Kaplan, Eric I. Benchimol +29 more
2023· review· en· Journal of the Canadian Association of Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations

How this was built: Screen · Findings · About